RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      FGFR2 gene amplification status and its clinicopathologic significance in gastric carcinoma

      한글로보기

      https://www.riss.kr/link?id=T14066486

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Introduction : Fibroblast growth factor receptor 2 (FGFR2) is a member of the FGFR receptor tyrosine kinase family, and FGFR2 gene amplification or missense mutation has been observed in various human cancers, including gastric carcinoma. Furthermore, recent studies have shown that anti-FGFR2 agents inhibit tumor progression in various human cancers, such as endometrial carcinoma and gastric carcinoma, which remains one of the most frequent causes of cancer-related death worldwide. We considered that knowledge of the status of FGFR2 gene amplification in gastric carcinoma may aid in targeted cancer therapy. Methods: In this study, FGFR2 amplification status was evaluated using fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain reaction (PCR) in 313 surgically resected gastric carcinoma tissues. FGFR2 gene copy number alteration was also evaluated in 372 gastric carcinoma tissues by FISH method. In addition, potential associations between clinicopathological parameters and the presence of FGFR2 amplification or copy number gain was investigated and survival analysis was performed Results: In our study, the frequency of FGFR2 amplification was 4.0% and 4.5% in the 2 groups of patients. FGFR2 amplification was also found to be associated with a higher pathologic T stage (p=0.023), pathologic N stage (p=0.038) and distant metastasis (p=0.009). In addition, univariate analysis revealed that FGFR2 copy number gain as well as amplification was significantly associated with lower cancer-specific survival. Conclusion: We therefore found gastric carcinoma with FGFR2 amplification or FGFR2 copy number gain to be associated with advanced disease. We believe that the determination of FGFR2 gene status could allow the identification of a subset of cancers sensitive to targeted FGFR2 inhibitor - based therapies.
      번역하기

      Introduction : Fibroblast growth factor receptor 2 (FGFR2) is a member of the FGFR receptor tyrosine kinase family, and FGFR2 gene amplification or missense mutation has been observed in various human cancers, including gastric carcinoma. Furthermore,...

      Introduction : Fibroblast growth factor receptor 2 (FGFR2) is a member of the FGFR receptor tyrosine kinase family, and FGFR2 gene amplification or missense mutation has been observed in various human cancers, including gastric carcinoma. Furthermore, recent studies have shown that anti-FGFR2 agents inhibit tumor progression in various human cancers, such as endometrial carcinoma and gastric carcinoma, which remains one of the most frequent causes of cancer-related death worldwide. We considered that knowledge of the status of FGFR2 gene amplification in gastric carcinoma may aid in targeted cancer therapy. Methods: In this study, FGFR2 amplification status was evaluated using fluorescence in situ hybridization (FISH) and quantitative real-time polymerase chain reaction (PCR) in 313 surgically resected gastric carcinoma tissues. FGFR2 gene copy number alteration was also evaluated in 372 gastric carcinoma tissues by FISH method. In addition, potential associations between clinicopathological parameters and the presence of FGFR2 amplification or copy number gain was investigated and survival analysis was performed Results: In our study, the frequency of FGFR2 amplification was 4.0% and 4.5% in the 2 groups of patients. FGFR2 amplification was also found to be associated with a higher pathologic T stage (p=0.023), pathologic N stage (p=0.038) and distant metastasis (p=0.009). In addition, univariate analysis revealed that FGFR2 copy number gain as well as amplification was significantly associated with lower cancer-specific survival. Conclusion: We therefore found gastric carcinoma with FGFR2 amplification or FGFR2 copy number gain to be associated with advanced disease. We believe that the determination of FGFR2 gene status could allow the identification of a subset of cancers sensitive to targeted FGFR2 inhibitor - based therapies.

      더보기

      목차 (Table of Contents)

      • Introduction 1
      • Materials and Methods 5
      • Results 14
      • Introduction 1
      • Materials and Methods 5
      • Results 14
      • Discussion 45
      • References 52
      • Abstract (Korean) 60
      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼